Pharmacoeconomy in acne - Evaluation of benefit and economics;Pharmakoökonomie der akne - Bewertung von nutzen und wirtschaftlichkeit

JDDG - Journal of the German Society of Dermatology

Volumn 8, Issue SUPPL. 1, 2010, Pages

  Radtke, Marc A ^a   Schäfer, Ines ^a   Augustin, Matthias ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Acne vulgaris; Benefit of drugs; Cost relationship; Pharmacoeconomy

Indexed keywords

ADAPALENE; AZELAIC ACID; BENZOYL PEROXIDE; CLINDAMYCIN; CYPROTERONE ACETATE; ERYTHROMYCIN; ETHINYLESTRADIOL; ISOTRETINOIN; MINOCYCLINE; RETINOIC ACID; RETINOID; TAZAROTENE; TETRACYCLINE; ZINC ACETATE;

ACNE; ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DAILY LIFE ACTIVITY; DRUG COST; DRUG EFFICACY; GERMANY; HUMAN; PATIENT COMPLIANCE; PREVALENCE; PROPIONIBACTERIUM ACNES; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; SOCIAL LIFE; SYSTEMATIC REVIEW; SYSTEMIC THERAPY; TOPICAL TREATMENT; ACNE VULGARIS; ADOLESCENT; ADULT; CHILD; CROSS-SECTIONAL STUDY; ECONOMICS; PSYCHOLOGY; PUBLIC HEALTH; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ACNE VULGARIS; ADOLESCENT; ADULT; CHILD; COST-BENEFIT ANALYSIS; CROSS-SECTIONAL STUDIES; DRUG COSTS; GERMANY; HUMANS; NATIONAL HEALTH PROGRAMS; QUALITY OF LIFE; YOUNG ADULT;

EID: 77951459693     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2009.07175.x     Document Type: Article

References (52)

1. Rice T. Stichwort Gesundheitsökonomie. Eine kritische Auseinandersetzung. KomPart Verlag, Bonn, 2004.
2. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmers. 3rd edition, Oxford University Press, Oxford, 2005.
3. Beyer F, Zweifel P, Kifmann M. Gesundheitsökonomik. 5. Auflage, Springer, Berlin, Heidelberg, 2005.
4. Rychlik R, Wertheimer A, Rusche H, Augustin M, Nelles S, Böcking W. Policy decision making and outcomes research in drug utilization. Z Gesundheitswiss / J Public Health 1 2005: 1-14.
5. Stathakis V, Kilkenny M, Marks R. Descriptive epidemiology of acne vulgaris in the community. Aust J Dermatol 1997; 38: 115-123 (Pubitemid 27382402)
6. Schaefer I, Zimmer L, Rustenbach SJ, Augustin M. Prevalence of skin diseases in a cohort of 48,665 employees in Germany. Dermatology 2008; 217(2): 169-172
7. Jansen T, Grabbe S, Plewig G. Akne im Kindesalter. Hautarzt 2006; 57: 222-227
8. Cunliffe WJ, Gould DJ. Prevalence of facial acne vulgaris in late adolescence and in adults. Br med J 1979; 1(6171): 1109-1110
9. Poli F, Dreno B, Verschoores. An epidemiological study of acne in female adults: results of a survey conducted in France. JEADV 2001; 15: 541-545
10. AWMF-Leitlinien zur Akne aktuelle Fassungen: http://www.uni-decesseldorf. de/AWMF
11. Cunliffe WJ, Layton A. Oral isotretinoin: patient selection and management. J Dermatol Treatment 1993; 4(Suppl2): 10-15.
12. Roebuck HL. Acne: intervene early. Nurse Pract 2006;31 (10): 24-43.
13. Augustin M, Reich C, Schaefer I, Zschocke I, Rustenbach SJ. Entwick-lung und Validierung eines neuen Instrumentes zur Erfassung patientendefinierten Nutzens in der Therapie der Akne. J Dtsch Dermatol Ges 2008; 6: 1-8.
14. Franzke N, Zimmer L, Schäfer I, Radermacher C, Kresken J, Radtke M, Augustin M. Versorgung der Akne vulgaris in Deutschland - Patientenbefragung in einem bundesweiten Apothekennetzwerk. J Dtsch Dermatol Ges. 2009 Jul 1. [Epub ahead of print].
15. Rost M, Tscheulin D, Augustin M. Modellanalyse zu den Krankheitskosten der Akne vulgaris in Deutschland. Schriftenreihe der Albert- LudwigsUniversität Freiburg, 2000.
16. Radtke M, Pindl M, Zieboldt M, Augustin M. Krankheitskosten häufiger Hauterkrankungen in einer deutschen Hautklinik. Manuscript submitted, 2008.
17. Simpson N. Effect of isotretinoin on the quality of life of patients with acne. Pharmacoeconomics 1994; 6(2): 108-113
18. Tan AW, Tan HH. Acne vulgaris: a review of antibiotic therapy. Expert Opinion Pharmacother 2005; 6(3): 409-418 (Pubitemid 40521078)
19. Plewig G, Albrecht G, Henz BM, Meigel W, Schöpf E, Stadler R. Systemische Behandlung der Akne mit Isotretinoin: Aktueller Stand. Hautarzt 1997; 48: 881-885 (Pubitemid 28034355)
20. No authors listed. Is Minocycline overused in acne. Drug Ther Bull 2006; 44(8): 60-62
21. Ozolins M, Eady EA, Avery AJ, Cunliff WJ, Po AL, O'Neill C, Simpson NB, Walters CE, Carnegie E, Lewis JB, Dada J, Haynes M, Williams K, Williams HC. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet 2004; 364(9452): 2188-2195 (Pubitemid 40018448)
22. Bossuyt L, Bosschaert J, Richert B, Cromphaut P, Mitchell T, Al Abadie M, Henry I, Bewley A, Poyner T, Mann N, Czernielewski J. Lymecycline in the treatment of acne: an efficacious, safe and cost-effective alternative to minocycline. Eur J Dermatol. 2003; 13(2): 130-135 (Pubitemid 36428356)
23. Cunliffe WJ, Grosshans E, Belaich S, Meynadier J, Alirezai M, Thomas LA. Comparison of the efficacy and safety of lymecycline and minocycline in pati- ents with moderately severe Acne vulgaris. Eur J Dermatol 1998; 8: 161-166 (Pubitemid 28218590)
24. Cunliffe WJ, Meynadier J, Alirezai M, George SA, Courts I, Roseeuw DI, Hachem JP, Briantais P, Sidou F, Soto P. Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0.1 %, versus lymecycline plus gel vehicle. J Am Acad Dermatol 2003; 49(3 Suppl): S218-26. (Pubitemid 37046536)
25. (a) Adjadj L. Cost-effectiveness of the combination of lymecycline with adapalene in the treatment of acne. J Eur Acad Dermatol Venerol 2003; 17(S3): 165.
26. (b) Augustin M, Reich C, Reinhardt W, Eicke C, Radtke M, Rustenbach J, Zschocke I. Nutzen und Wirtschaftlichkeit von Duac Gel bei Akne vulgaris. J Dtsch Dermatol Ges 2007; 5(S2): 31.
27. (c) Langner A, Chu A, Goulden V, Ambroziak M. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris. Br J Dermatol 2008; 158(1): 122-129
28. Webster GF, Guenther L, Polin YP, Solomon BA, Loven K, Lee J. A multicenter, double-blind, randimized comparison study of the efficacy and tolerability of once-daily tazarotene 0,1 % gel and adapalene 0,1 % gel fort he treatment of facial acne vulgaris. Cutis 2002; 69 (2 Suppl): 4-11.
29. Leyden JJ, Tanghetti EA, Miller B, Ung M, Berson D, Lee J. Once-daily tazaroten 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a doubleblind randomized trial. Cutis 2002;69 (2 Suppl.): 12-19
30. Harper J. The use of topical retinoids for inflammatory acne: a review of the pharmacoeconomic considerations. Manag Care Interface 2005; 18(3): 51-55 (Pubitemid 40740536)
31. Tan HH. Antibacterial therapy for acne: a guide to selection and use of systemic agents. Am J Clin Dermatol 2003; 4(5): 307-314
32. Hartmann D, Bollag W Historical aspects of the oral use of retinoids in acne. J Dermatol 1993; 20: 674-678 (Pubitemid 24025202)
33. Farrell LN, Strauss JS, Stranieri AM. The treatment of severe cystic acne with 13-cis-retinoic acid: Evaluation of sebum production and the clinical response in a multi-dose-trial. J Am Acad Dermatol 1980; 3: 602-611
34. Cunliffe WJ, van de Kerkhof PCM, Caputo R, Cavicchini S, Cooper A, Fryand OL, Gollnick H, Layton AM, Leyden JJ, Mascaro JM, Ortonne JP, Shalita A: Roaccutane treatment guidelines: Results of an international survey. Dermatology 1997; 194: 351-357 (Pubitemid 27290560)
35. Layton A, Knaggs H, Taylor J, Cunliff WJ. Isotretinoin for acne vulgaris - 10 years later: a safe and successful treatment. Br J Dermatol 1993; 129: 292-296 (Pubitemid 23284001)
36. Warren KJ, Cruz PD. Clinical outcome and cost analysis of oral isotretinoin versus conventional regimens in the treatment of moderate acne vulgaris in male patients. Pediatr Dermatol 1998; 15: 329-331
37. Wessels F, Anderson AN, Kropman K. The cost-effectiveness of isotretinoin in the treatment of acne. Part 3. A cost-minimisation pharmaco-economic model. S Afr Med J 1999; 89(7 Pt 2): 791-794
38. Lee ML, Cooper A. Isotretinoin: cost benefit study. Australasian J Dermatol. 1991;32:17-20.
39. Newton JN. How Cost-Effective Is Oral Isotretinoin? Dermatology 1997; 195(suppl 1): 10-14
40. Plewig G, Dressel H, Pfleger M, Michelsen S, Kligman AM. Low dose isotretinoin combined widi tretinoin is effective to correct abnormalities of acne. J Dtsch Dermatol Ges 2004; 2(1): 31-45. (Pubitemid 38176130)
41. Tan JK. Perspectives on isotretinoin and the Canadian Consensus Guidelines on treatment of acne. Skin Therapy Lett 2000; 6(2): 1-4.
42. Ortonne JP. Oral isotretinoin treatment policy. Dermatology 1997; 195 (Suppl 1): 34-37
43. Honein MA, Paulozzi LJ. Cost-effectiveness of oral isotretinoin. Dermatolology 1999; 198:404-405
44. Chan A, Keane RJ, Hanna M, Abbott M. Terminations of pregnancy for exposure to oral retinolid in South Australia, 1985-1993. Aust NZ J Obstet Gynaecol 1995; 35: 422-426
45. Zaghloul SS, Cunliffe WJ, Goodfield MJ. Objective assessment of compliance with treatments in acne. Br J Dermatol 2005; 152(5): 1015-1021
46. Balkrishnan R, Kulkarni AS, Cayce K, Feldman SR. Predictors of healthcare outcomes and costs related to medication use in patients with acne in the United States. Cutis 2006; 77(4): 251-255 (Pubitemid 43723545)
47. Haider A, Mamdani M, Shawn JC, Alter DA, Shear NH. Socioeconomic status influences care of patients with acne in Ontario, Canada. J Am Acad Dermatol 2006; 54(2): 331-335 (Pubitemid 43144410)
48. Cotterill JA, Cunliff WJ. Suicide in dermatological patients. Br J Dermatol 1997; 137: 246-250
49. Garrie SA, Garrie EV. Anxiety and skin diseases. Cutis 1978; 22: 205-208
50. Lim CC, Tan TC. Personality, disability and acne in college students. Clin Exp Dermatol 1991; 16: 371-373
51. Gupta MA, Gupta AK, Schork NJ, Ellis CN, Voorhees JJ. Psychiatric aspects of the treatment of mild to moderate facial acne. Some preliminary observations. Int J Dermatol 1990; 29(10): 719-721
52. Cunliffe WJ. Acne and unemployment. Br J Dermatol 1986; 115: 386.